Feb 27, 2022 / 11:00PM GMT
Operator
Good day, and thank you for standing by. And welcome to the Next Science Limited 2021 Full Year Results Conference Call. (Operator Instructions) After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions)
I'd now like to hand the conference over to your first speaker today, Managing Director, Judith Mitchell. Thank you. Please go ahead.
Judith Mitchell - Next Science Limited - MD, CEO & Executive Director
Thank you very much, and good morning, everybody, and thank you for joining us on the call this morning. My name is Judy Mitchell, and I'm the Managing Director for Next Science. So, let's start by moving to Slide 3 on the deck that was put up on the ASX on the 23rd of this month -- of, yes, this month, February. So we are actually very happy to report that 2021 was a record year of sales for the company with 160% growth year-on-year. We saw record growth in Bactisure sales as the surgery market started to recover in the U.S. We saw expansion of our BlastX customer base as we pulled the product back from
Full Year 2021 Next Science Ltd Earnings Call Transcript
Feb 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers